RetinalGenix FY26 Q2 net loss narrows 53% to $307,397 - RTGN News | RalliesRetinalGenix FY26 Q2 net loss narrows 53% to $307,397
R
RTGN• Quarterly loss narrows as expenses decline
- RetinalGenix posted a GAAP net loss of $307,397 for the quarter ended June 30, 2026, narrowing 53% year over year.
- Total GAAP expenses fell 53% to $303,442, driven by a 45% drop in general and administrative costs to $212,254.
- Research and development spending more than doubled to $66,406, reflecting work with engineering and technology consultants on RetinalCam.
- Liquidity remained tight with cash of $27,232 at June 30, 2026; management said it lacks resources to fund operations beyond June 2026.
- The company reiterated plans to launch RetinalCam in the second half of 2026; it also expects to need about $7 million in additional capital.
•
